BUTENAFINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Butenafine Hydrochloride patents expire, and what generic alternatives are available?
Butenafine Hydrochloride is a drug marketed by Taro and is included in one NDA.
The generic ingredient in BUTENAFINE HYDROCHLORIDE is butenafine hydrochloride. There are two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Butenafine Hydrochloride
A generic version of BUTENAFINE HYDROCHLORIDE was approved as butenafine hydrochloride by TARO on November 16th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUTENAFINE HYDROCHLORIDE?
- What are the global sales for BUTENAFINE HYDROCHLORIDE?
- What is Average Wholesale Price for BUTENAFINE HYDROCHLORIDE?
Summary for BUTENAFINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 4 |
| Patent Applications: | 321 |
| DailyMed Link: | BUTENAFINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BUTENAFINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| United Laboratories | Phase 2 |
| Taro Pharmaceuticals USA | Phase 1 |
Pharmacology for BUTENAFINE HYDROCHLORIDE
| Drug Class | Benzylamine Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for BUTENAFINE HYDROCHLORIDE
US Patents and Regulatory Information for BUTENAFINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | BUTENAFINE HYDROCHLORIDE | butenafine hydrochloride | CREAM;TOPICAL | 205181-001 | Nov 16, 2017 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
